BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elkhalifa D, Al-Hashimi I, Al Moustafa AE, Khalil A. A comprehensive review on the antiviral activities of chalcones. J Drug Target 2021;29:403-19. [PMID: 33232192 DOI: 10.1080/1061186X.2020.1853759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Park RY, Lee H, Park K. Total synthesis of 2′,4′,6′‐trimethoxy‐3′,5′‐dimethylchalcone derivatives. Bulletin Korean Chem Soc. [DOI: 10.1002/bkcs.12515] [Reference Citation Analysis]
2 Mothana RA, Arbab AH, Elgamal AA, Parvez MK, Al-dosari MS. Isolation and Characterization of Two Chalcone Derivatives with Anti-Hepatitis B Virus Activity from the Endemic Socotraen Dracaena cinnabari (Dragon’s Blood Tree). Molecules 2022;27:952. [DOI: 10.3390/molecules27030952] [Reference Citation Analysis]
3 Zhang J, Lv J, Wang J. The crystal structure of ( E )-1-(4-aminophenyl)-3-( p -tolyl)prop-2-en-1-one, C 16 H 15 NO. Zeitschrift für Kristallographie - New Crystal Structures 2022;0. [DOI: 10.1515/ncrs-2022-0039] [Reference Citation Analysis]
4 Afonin AV, Rusinska-Roszak D. Guide to tuning the chalcone molecular properties based on the push-pull effect energy scale created via the molecular tailoring approach. J Comput Chem 2022. [PMID: 35175632 DOI: 10.1002/jcc.26827] [Reference Citation Analysis]
5 Jasim HA, Nahar L, Jasim MA, Moore SA, Ritchie KJ, Sarker SD. Chalcones: Synthetic Chemistry Follows Where Nature Leads. Biomolecules 2021;11:1203. [PMID: 34439870 DOI: 10.3390/biom11081203] [Reference Citation Analysis]
6 Tumskiy RS, Tumskaia AV. Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro. Chem Phys Lett 2021;780:138894. [PMID: 34276059 DOI: 10.1016/j.cplett.2021.138894] [Reference Citation Analysis]
7 Luo W, Yang LB, Qian CC, Ma B, Manjengwa GM, Miao XM, Wang J, Hu CH, Jin B, Zhang LX, Zheng C, Liang G, Wang Y. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2. Acta Pharmacol Sin 2021. [PMID: 34737421 DOI: 10.1038/s41401-021-00792-4] [Reference Citation Analysis]